Literature DB >> 17404900

Measuring social difficulties in routine patient-centred assessment: a Rasch analysis of the social difficulties inventory.

Adam B Smith1, Penny Wright, Peter Selby, Galina Velikova.   

Abstract

BACKGROUND: Social difficulties may add to the psychological burden experienced by cancer patients. Therefore identifying social difficulties in routine oncology practice may help prevent or alleviate distress. The Social Difficulties Inventory (SDI) is a short questionnaire developed for assessing social difficulties in cancer patients. Although well-validated, not enough is known about the clinical meaning and utility of the instrument or whether the items can be meaningfully summed to form a summary index of "Social Distress".
PURPOSE: To determine, using Rasch analysis, whether the SDI could be used as a summary index of social distress specifically examining three fundamental criteria: item fit, unidimensionality and item invariance.
METHODS: The Partial Credit Model was applied to a heterogeneous sample of cancer patients (n = 609) who had completed the SDI.
RESULTS: Five items were identified as misfitting (infit mean square > or = 1.3 and standardised t-statistic > or = 2) and excluded from the subsequent analysis. The remaining items formed a unidimensional interval scale with no additional factors identified in a principal components analysis of the residuals. No differential item functioning was observed for age, gender, diagnosis, extent of disease or social deprivation. The 16-item SDI can be summed to produce an overall index of social distress, facilitating routine identification of social difficulties. Subsequent work is needed to evaluate whether the instrument is able to identify patients with high levels of social distress requiring intervention.

Entities:  

Mesh:

Year:  2007        PMID: 17404900     DOI: 10.1007/s11136-007-9181-9

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   3.440


  14 in total

1.  Detecting and evaluating the impact of multidimensionality using item fit statistics and principal component analysis of residuals.

Authors:  Everett V Smith
Journal:  J Appl Meas       Date:  2002

2.  Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire.

Authors:  Morten Aa Petersen; Mogens Groenvold; Jakob B Bjorner; Neil Aaronson; Thierry Conroy; Ann Cull; Peter Fayers; Marianne Hjermstad; Mirjam Sprangers; Marianne Sullivan
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

3.  Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts.

Authors:  G Stucki; L Daltroy; J N Katz; M Johannesson; M H Liang
Journal:  J Clin Epidemiol       Date:  1996-07       Impact factor: 6.437

4.  Use of item response theory to develop a shortened version of the EORTC QLQ-C30 emotional functioning scale.

Authors:  J B Bjorner; M Aa Petersen; M Groenvold; N Aaronson; M Ahlner-Elmqvist; J I Arraras; A Brédart; P Fayers; M Jordhoy; M Sprangers; M Watson; T Young
Journal:  Qual Life Res       Date:  2004-12       Impact factor: 4.147

5.  Using item mean squares to evaluate fit to the Rasch model.

Authors:  R M Smith; R E Schumacker; M J Bush
Journal:  J Outcome Meas       Date:  1998

6.  The need for a new medical model: a challenge for biomedicine.

Authors:  G L Engel
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

7.  Rasch fit statistics as a test of the invariance of item parameter estimates.

Authors:  Richard M Smith; Kyunghee K Suh
Journal:  J Appl Meas       Date:  2003

8.  Feasibility and compliance of automated measurement of quality of life in oncology practice.

Authors:  E P Wright; P J Selby; M Crawford; A Gillibrand; C Johnston; T J Perren; R Rush; A Smith; G Velikova; K Watson; A Gould; A Cull
Journal:  J Clin Oncol       Date:  2003-01-15       Impact factor: 44.544

9.  Social problems in oncology.

Authors:  E P Wright; M A Kiely; P Lynch; A Cull; P J Selby
Journal:  Br J Cancer       Date:  2002-11-04       Impact factor: 7.640

10.  Psychosocial difficulties, deprivation and cancer: three questionnaire studies involving 609 cancer patients.

Authors:  P Wright; A Smith; L Booth; A Winterbottom; M Kiely; G Velikova; P Selby
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

View more
  7 in total

Review 1.  Assessing the social impact of cancer: a review of available tools.

Authors:  Barbara Muzzatti; M Antonietta Annunziata
Journal:  Support Care Cancer       Date:  2012-08-07       Impact factor: 3.603

2.  Measurement invariance of the 16-item social distress scale.

Authors:  Adam B Smith; Penny Wright; Peter Selby; Galina Velikova
Journal:  Qual Life Res       Date:  2010-11-05       Impact factor: 4.147

3.  Translation of the Social Difficulties Inventory (SDI-21) into three South Asian languages and preliminary evaluation of SDI-21(Urdu).

Authors:  Naheed Hanif; Nimarta Dharni; Adam Smith; Sangeeta Chattoo; Galina Velikova; Chris Bradley; Dan Stark; Penny Wright
Journal:  Qual Life Res       Date:  2010-10-15       Impact factor: 4.147

Review 4.  Patient-reported outcome measures of the impact of cancer on patients' everyday lives: a systematic review.

Authors:  Susan Catt; Rachel Starkings; Valerie Shilling; Lesley Fallowfield
Journal:  J Cancer Surviv       Date:  2016-11-10       Impact factor: 4.442

5.  Prevalence vs impact: a mixed methods study of survivorship issues in colorectal cancer.

Authors:  Amanda Drury; Sheila Payne; Anne-Marie Brady
Journal:  Qual Life Res       Date:  2021-08-21       Impact factor: 4.147

6.  Rasch fit statistics and sample size considerations for polytomous data.

Authors:  Adam B Smith; Robert Rush; Lesley J Fallowfield; Galina Velikova; Michael Sharpe
Journal:  BMC Med Res Methodol       Date:  2008-05-29       Impact factor: 4.615

7.  Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory.

Authors:  P Wright; A Smith; K Roberts; P Selby; G Velikova
Journal:  Br J Cancer       Date:  2007-09-25       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.